Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The MTHFR C677T polymorphism and prostate cancer risk: new findings from a meta-analysis of 7306 cases and 8062 controls.

Asian Pacific journal of cancer prevention : APJCP - 1 Jan 2012

Zhang Wei-Bing, Zhang Jun-Hong, Pan Zheng-Qi, Yang Qi-Sheng, Liu Bo

Abstract excerpt

Methylenetetrahydrofolate reductase (MTHFR) is an essential enzyme involved in folate metabolism; a single nucleotide polymorphism (SNP) C677T has been reported to be linked with altered incidences of several diseases. We here conducted a meta-analysis of 15 published epidemiological studies with a total of 7306 cases and 8062 controls to evaluate its association with prostate cancer risk with overall and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Gene Frequency
Share to MTHFR gene

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Predisposition to Disease

Share to Genotype

Share to Methylenetetrahydrofolate Reductase (NADPH2)

Share to Polymorphism, Single Nucleotide

Share to Prostatic Neoplasms

Share to Risk Factors

Source

Identifiers

PMID: 22938427
DOI: 10.7314/apjcp.2012.13.6.2597

Genes

MTHFR

Variants

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The MTHFR C677T polymorphism and prostate cancer risk: new findings from a meta-analysis of 7306 cases and 8062 controls.PMID 22938427Read ↗

Association between MTHFR C677T Polymorphism and Risk of Prostate Cancer: Evidence from 22 Studies with 10,832 Cases and 11,993 Controls.Semantic proximity Read ↗

MTHFR polymorphism and the risk of prostate cancer: a meta-analysis of case-control studies.Semantic proximity Read ↗

The protective effect of methylenetetrahydrofolate reductase C677T polymorphism against prostate cancer risk: Evidence from 23 case-control studies.Semantic proximity Read ↗

MTHFR C677T polymorphism contributes to prostate cancer risk among Caucasians: A meta-analysis of 3511 cases and 2762 controls.Semantic proximity Read ↗

Association between MTHFR gene polymorphisms (C677T, A1298C) and genetic susceptibility to prostate cancer: a meta-analysis.Semantic proximity Read ↗

Significant association of methylenetetrahydrofolate reductase single nucleotide polymorphisms with prostate cancer susceptibility in taiwan.Semantic proximity Read ↗

Association of folate-pathway gene polymorphisms with the risk of prostate cancer: a population-based nested case-control study, systematic review, and meta-analysis.Semantic proximity Read ↗

Relationship between three polymorphisms of methylenetetrahydrofolate reductase (MTHFR C677T, A1298C, and G1793A) gene and risk of prostate cancer: a case-control study.Semantic proximity Read ↗

MTHFR c.677C>T Inhibits Cell Proliferation and Decreases Prostate Cancer Susceptibility in the Han Chinese Population in Shanghai.Semantic proximity Read ↗

Analysis of relation between C677T genotype in MTHFR gene and prostatic cancer in Iranian males.Semantic proximity Read ↗

Effects of the MTHFR C677T polymorphism on prostate specific antigen and prostate cancer.Semantic proximity Read ↗

Polymorphisms of methylenetetrahydrofolate reductase and the risk of prostate cancer: a nested case-control study.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.